Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
Clinical trial NCT02613507 · COMPLETED
Trial details
- NCT number
- NCT02613507
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-11
- Primary completion
- 2017-09-15
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.